Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All melatonin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchMelatoninMelatonin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

The Potential of Melatonin and N-Acetylcysteine on Remdesivir Induced Liver Injury in Covid 19 Patients

Karimi et al., Advances in Animal and Veterinary Sciences, doi:10.17582/journal.aavs/2023/11.3.404.409, IRCT20210926052586N2
Feb 2023  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Melatonin for COVID-19
11th treatment shown to reduce risk in December 2020, now with p = 0.0000002 from 18 studies.
Lower risk for mortality, ventilation, and recovery.
No treatment is 100% effective. Protocols combine treatments.
5,000+ studies for 109 treatments. c19early.org
RCT 70 hospitalized COVID-19 patients evaluating the effects of N-acetylcysteine (NAC) and melatonin on liver injury induced by remdesivir treatment. NAC 600mg twice daily and melatonin 6mg daily. All patients received remdesivir. Liver enzymes (AST, ALT, ALP) and CBC levels were measured on days 1, 3 and 6. Levels were lower in the treatment group but the differences were not statistically significant. The treatment group was older (63 vs. 55) and had more severe patients (24% vs. 8%). Authors recommend further studies with longer duration and different doses to establish if these antioxidants can reduce remdesivir hepatotoxicity.
Study covers remdesivir, melatonin, and N-acetylcysteine.
Karimi et al., 13 Feb 2023, Double Blind Randomized Controlled Trial, placebo-controlled, Iran, peer-reviewed, mean age 63.4, 5 authors, trial IRCT20210926052586N2. Contact: mohamdarvishii@gmail.com.
This PaperMelatoninAll
{ 'indexed': {'date-parts': [[2023, 2, 13]], 'date-time': '2023-02-13T05:12:57Z', 'timestamp': 1676265177446}, 'reference-count': 0, 'publisher': 'ResearchersLinks Ltd', 'issue': '3', 'content-domain': {'domain': ['researcherslinks.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2023]]}, 'DOI': '10.17582/journal.aavs/2023/11.3.404.409', 'type': 'journal-article', 'created': {'date-parts': [[2023, 2, 12]], 'date-time': '2023-02-12T14:05:41Z', 'timestamp': 1676210741000}, 'update-policy': 'http://dx.doi.org/10.17582/journal.aavs/2023/11.3.404.409', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'The Potential of Melatonin and N-Acetylcysteine on Remdesivir Induced Liver Injury in Covid 19 ' 'Patients', 'prefix': '10.17582', 'volume': '11', 'author': [ {'given': 'Seyedmohammad', 'family': 'Karimi', 'sequence': 'first', 'affiliation': []}, {'given': 'Mohammad', 'family': 'Darvishi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mohammad', 'family': 'Barati', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ramin Hamidi', 'family': 'Frahani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mohammad Hassan', 'family': 'Kazemi', 'sequence': 'additional', 'affiliation': []}], 'member': '7005', 'published-online': {'date-parts': [[2023, 2, 13]]}, 'container-title': 'Advances in Animal and Veterinary Sciences', 'original-title': [], 'deposited': { 'date-parts': [[2023, 2, 12]], 'date-time': '2023-02-12T14:05:49Z', 'timestamp': 1676210749000}, 'score': 1, 'resource': { 'primary': { 'URL': 'http://researcherslinks.com/current-issues/The-Potential-Melatonin-and-N-Acetylcysteine/33/8/5944/html'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2023]]}, 'references-count': 0, 'journal-issue': { 'issue': '3', 'published-online': {'date-parts': [[2023, 2, 13]]}, 'published-print': {'date-parts': [[2023]]}}, 'URL': 'http://dx.doi.org/10.17582/journal.aavs/2023/11.3.404.409', 'relation': {}, 'ISSN': ['2307-8316'], 'subject': ['General Veterinary', 'Animal Science and Zoology'], 'container-title-short': 'AAVS', 'published': {'date-parts': [[2023]]}}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit